- Filed
- Mar 5, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | FY 2025 · Feb 27, 2026 | 3.56M sh |
| Shares Diluted | FY 2025 · Dec 31, 2025 | 2.84M sh |
| Shares Diluted restated | FY 2025 · Dec 31, 2024 | 2.33M sh |
| Operating Cash Flow | FY 2025 · Dec 31, 2025 | −$49.61M |
| Operating Cash Flow | FY 2025 · Dec 31, 2024 | −$40.81M |
| Cash And Equivalents | FY 2025 · Dec 31, 2025 | $25.98M |
| Cash And Equivalents | FY 2025 · Dec 31, 2024 | $27.73M |
| Stockholders Equity | FY 2025 · Dec 31, 2025 | $34.94M |
| Stockholders Equity | FY 2025 · Dec 31, 2024 | $65.47M |
| Stockholders Equity | FY 2025 · Dec 31, 2023 | $114.42M |
| Current Liabilities | FY 2025 · Dec 31, 2025 | $10.57M |
| Current Liabilities | FY 2025 · Dec 31, 2024 | $9.57M |
| Total Liabilities | FY 2025 · Dec 31, 2025 | $15.24M |
| Total Liabilities | FY 2025 · Dec 31, 2024 | $15.39M |
| Current Assets | FY 2025 · Dec 31, 2025 | $43.75M |
| Current Assets | FY 2025 · Dec 31, 2024 | $71.81M |
| Total Assets | FY 2025 · Dec 31, 2025 | $50.18M |
| Total Assets | FY 2025 · Dec 31, 2024 | $80.86M |
| Eps Diluted | FY 2025 · Dec 31, 2025 | −$19.65 |
| Eps Diluted restated | FY 2025 · Dec 31, 2024 | −$23.88 |
| Eps Basic | FY 2025 · Dec 31, 2025 | −$19.65 |
| Eps Basic restated | FY 2025 · Dec 31, 2024 | −$23.88 |
| Sga Expense | FY 2025 · Dec 31, 2025 | $12.69M |
| Sga Expense | FY 2025 · Dec 31, 2024 | $15.72M |
| Rd Expense | FY 2025 · Dec 31, 2025 | $44.92M |
| Rd Expense | FY 2025 · Dec 31, 2024 | $41.49M |
| Net Income | FY 2025 · Dec 31, 2025 | −$55.84M |
| Net Income | FY 2025 · Dec 31, 2024 | −$55.65M |
| Operating Income | FY 2025 · Dec 31, 2025 | −$57.62M |
| Operating Income | FY 2025 · Dec 31, 2024 | −$59.75M |
| Capex | FY 2025 · Dec 31, 2024 | $474K |